Endothelial MRTF-A mediates angiotensin II induced cardiac hypertrophy

Journal of Molecular and Cellular Cardiology

Volumn 80, Issue , 2015, Pages 23-33

  Weng, Xinyu ^a   Yu, Liming ^a   Liang, Peng ^a   Chen, Dewei ^b   Cheng, Xian ^a,d   Yang, Yuyu ^a,e   Li, Luyang ^a   Zhang, Ting ^a   Zhou, Bisheng ^a   Wu, Xiaoyan ^a   Xu, Huihui ^a   Fang, Mingming ^a,c   Gao, Yuqi ^b   Chen, Qi ^a   Xu, Yong ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

^c Jiangsu Jiankang Vocational Institute   (China)

^d JIANGSU INSTITUTE OF NUCLEAR MEDICINE   (China)

^e CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Angiotensin II; Cardiac hypertrophy; Endothelial cell; Endothelin 1; MRTF A; Transcriptional regulation

Indexed keywords

ANGIOTENSIN II; ENDOTHELIN 1; HISTONE H3; MYOCARDIN RELATED TRANSCRIPTION FACTOR A; PROTEIN C FOS; PROTEIN C JUN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; MKL1 PROTEIN, MOUSE; PROTEIN BINDING; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHROMATIN STRUCTURE; CONTROLLED STUDY; ENDOTHELIN 1 GENE; ENDOTHELIUM CELL; GENE ACTIVATION; HEART VENTRICLE HYPERTROPHY; HISTONE ACETYLATION; HISTONE METHYLATION; HUMAN; HUMAN CELL; MALE; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; PROTEIN SYNTHESIS; TRANSACTIVATION; ANIMAL; BIOLOGICAL MODEL; CARDIOMEGALY; CELL LINE; DISEASE MODEL; DRUG EFFECTS; FIBROSIS; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; METABOLISM; PATHOLOGY; TRANSCRIPTION INITIATION; VASCULAR ENDOTHELIUM;

MUS;

ANGIOTENSIN II; ANIMALS; CARDIOMEGALY; CELL LINE; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; EPIGENESIS, GENETIC; FIBROSIS; GENE EXPRESSION REGULATION; HUMANS; MICE; MODELS, BIOLOGICAL; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; TRANS-ACTIVATORS; TRANSCRIPTIONAL ACTIVATION;

EID: 84920913657     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2014.11.009     Document Type: Article

References (59)

1. Dimmeler S., Rippmann V., Weiland U., Haendeler J., Zeiher A.M. Angiotensin II induces apoptosis of human endothelial cells. Protective effect of nitric oxide. Circ Res 1997, 81:970-976.
2. Imanishi T., Hano T., Nishio I. Angiotensin II accelerates endothelial progenitor cell senescence through induction of oxidative stress. J Hypertens 2005, 23:97-104.
3. Bendall J.K., Rinze R., Adlam D., Tatham A.L., de Bono J., Wilson N., et al. Endothelial Nox2 overexpression potentiates vascular oxidative stress and hemodynamic response to angiotensin II: studies in endothelial-targeted Nox2 transgenic mice. Circ Res 2007, 100:1016-1025.
4. Tummala P.E., Chen X.L., Sundell C.L., Laursen J.B., Hammes C.P., Alexander R.W., et al. Angiotensin II induces vascular cell adhesion molecule-1 expression in rat vasculature: a potential link between the renin-angiotensin system and atherosclerosis. Circulation 1999, 100:1223-1229.
5. Rao R.M., Yang L., Garcia-Cardena G., Luscinskas F.W. Endothelial-dependent mechanisms of leukocyte recruitment to the vascular wall. Circ Res 2007, 101:234-247.
6. Widyantoro B., Emoto N., Nakayama K., Anggrahini D.W., Adiarto S., Iwasa N., et al. Endothelial cell-derived endothelin-1 promotes cardiac fibrosis in diabetic hearts through stimulation of endothelial-to-mesenchymal transition. Circulation 2010, 121:2407-2418.
7. Amiri F., Virdis A., Neves M.F., Iglarz M., Seidah N.G., Touyz R.M., et al. Endothelium-restricted overexpression of human endothelin-1 causes vascular remodeling and endothelial dysfunction. Circulation 2004, 110:2233-2240.
8. Castanares C., Redondo-Horcajo M., Magan-Marchal N., ten Dijke P., Lamas S., Rodriguez-Pascual F. Signaling by ALK5 mediates TGF-beta-induced ET-1 expression in endothelial cells: a role for migration and proliferation. J Cell Sci 2007, 120:1256-1266.
9. Yamashita K., Discher D.J., Hu J., Bishopric N.H., Webster K.A. Molecular regulation of the endothelin-1 gene by hypoxia. Contributions of hypoxia-inducible factor-1, activator protein-1, GATA-2, AND p300/CBP. J Biol Chem 2001, 276:12645-12653.
10. Adiarto S., Heiden S., Vignon-Zellweger N., Nakayama K., Yagi K., Yanagisawa M., et al. ET-1 from endothelial cells is required for complete angiotensin II-induced cardiac fibrosis and hypertrophy. Life Sci 2012, 91:651-657.
11. Fang F., Yang Y., Yuan Z., Gao Y., Zhou J., Chen Q., et al. Myocardin-related transcription factor A mediates OxLDL-induced endothelial injury. Circ Res 2011, 108:797-807.
12. Yang Y., Chen D., Yuan Z., Fang F., Cheng X., Xia J., et al. Megakaryocytic leukemia 1 (MKL1) ties the epigenetic machinery to hypoxia-induced transactivation of endothelin-1. Nucleic Acids Res 2013, 41:6005-6017.
13. Small E.M., Thatcher J.E., Sutherland L.B., Kinoshita H., Gerard R.D., Richardson J.A., et al. Myocardin-related transcription factor-a controls myofibroblast activation and fibrosis in response to myocardial infarction. Circ Res 2010, 107:294-304.
14. Cao X.L., Hu X.M., Hu J.Q., Zheng W.X. Myocardin-related transcription factor-A promoting neuronal survival against apoptosis induced by hypoxia/ischemia. Brain Res 2011, 1385:263-274.
15. Kuwahara K., Kinoshita H., Kuwabara Y., Nakagawa Y., Usami S., Minami T., et al. Myocardin-related transcription factor A is a common mediator of mechanical stress- and neurohumoral stimulation-induced cardiac hypertrophic signaling leading to activation of brain natriuretic peptide gene expression. Mol Cell Biol 2010, 30:4134-4148.
16. Ly D.L., Waheed F., Lodyga M., Speight P., Masszi A., Nakano H., et al. Hyperosmotic stress regulates the distribution and stability of myocardin-related transcription factor, a key modulator of the cytoskeleton. Am J Physiol Cell Physiol 2013, 304:C115-C127.
17. Lee S.M., Vasishtha M., Prywes R. Activation and repression of cellular immediate early genes by serum response factor cofactors. J Biol Chem 2010, 285:22036-22049.
18. Sun Y., Boyd K., Xu W., Ma J., Jackson C.W., Fu A., et al. Acute myeloid leukemia-associated Mkl1 (Mrtf-a) is a key regulator of mammary gland function. Mol Cell Biol 2006, 26:5809-5826.
19. Yang L.L., Gros R., Kabir M.G., Sadi A., Gotlieb A.I., Husain M., et al. Conditional cardiac overexpression of endothelin-1 induces inflammation and dilated cardiomyopathy in mice. Circulation 2004, 109:255-261.
20. Hsu Y.H., Chen J.J., Chang N.C., Chen C.H., Liu J.C., Chen T.H., et al. Role of reactive oxygen species-sensitive extracellular signal-regulated kinase pathway in angiotensin II-induced endothelin-1 gene expression in vascular endothelial cells. J Vasc Res 2004, 41:64-74.
21. Shilatifard A. The COMPASS family of histone H3K4 methylases: mechanisms of regulation in development and disease pathogenesis. Annu Rev Biochem 2012, 81:65-95.
22. Fang F., Chen D., Yu L., Dai X., Yang Y., Tian W., et al. Proinflammatory stimuli engage brahma related gene 1 and brahma in endothelial injury. Circ Res 2013, 113:986-996.
23. Paddison P.J., Caudy A.A., Sachidanandam R., Hannon G.J. Short hairpin activated gene silencing in mammalian cells. Methods Mol Biol 2004, 265:85-100.
24. Hannon G.J., Rossi J.J. Unlocking the potential of the human genome with RNA interference. Nature 2004, 431:371-378.
25. Zhang T., Berrocal J.G., Frizzell K.M., Gamble M.J., DuMond M.E., Krishnakumar R., et al. Enzymes in the NAD+ salvage pathway regulate SIRT1 activity at target gene promoters. J Biol Chem 2009, 284:20408-20417.
26. Giering J.C., Grimm D., Storm T.A., Kay M.A. Expression of shRNA from a tissue-specific pol II promoter is an effective and safe RNAi therapeutic. Mol Ther 2008, 16:1630-1636.
27. Laurenti E., Barde I., Verp S., Offner S., Wilson A., Quenneville S., et al. Inducible gene and shRNA expression in resident hematopoietic stem cells in vivo. Stem Cells 2010, 28:1390-1398.
28. Horio E., Kadomatsu T., Miyata K., Arai Y., Hosokawa K., Doi Y., et al. Role of endothelial cell-derived angptl2 in vascular inflammation leading to endothelial dysfunction and atherosclerosis progression. Arterioscler Thromb Vasc Biol 2014, 34:790-800.
29. Chen D., Fang F., Yang Y., Chen J., Xu G., Xu Y., et al. Brahma-related gene 1 (Brg1) epigenetically regulates CAM activation during hypoxic pulmonary hypertension. Cardiovasc Res 2013, 100:363-373.
30. Roura S., Bayes-Genis A. Vascular dysfunction in idiopathic dilated cardiomyopathy. Nat Rev Cardiol 2009, 6:590-598.
31. Shah A.M., Lewis M.J. Endothelial modulation of myocardial contraction: mechanisms and potential relevance in cardiac disease. Basic Res Cardiol 1992, 87(Suppl. 2):59-70.
32. Tirziu D., Giordano F.J., Simons M. Cell communications in the heart. Circulation 2010, 122:928-937.
33. Shubeita H.E., McDonough P.M., Harris A.N., Knowlton K.U., Glembotski C.C., Brown J.H., et al. Endothelin induction of inositol phospholipid hydrolysis, sarcomere assembly, and cardiac gene expression in ventricular myocytes. A paracrine mechanism for myocardial cell hypertrophy. J Biol Chem 1990, 265:20555-20562.
34. Rizvi M.A., Katwa L., Spadone D.P., Myers P.R. The effects of endothelin-1 on collagen type I and type III synthesis in cultured porcine coronary artery vascular smooth muscle cells. J Mol Cell Cardiol 1996, 28:243-252.
35. Ding B.S., Nolan D.J., Butler J.M., James D., Babazadeh A.O., Rosenwaks Z., et al. Inductive angiocrine signals from sinusoidal endothelium are required for liver regeneration. Nature 2010, 468:310-315.
36. Ding B.S., Nolan D.J., Guo P., Babazadeh A.O., Cao Z., Rosenwaks Z., et al. Endothelial-derived angiocrine signals induce and sustain regenerative lung alveolarization. Cell 2011, 147:539-553.
37. Cao Z., Ding B.S., Guo P., Lee S.B., Butler J.M., Casey S.C., et al. Angiocrine factors deployed by tumor vascular niche induce B cell lymphoma invasiveness and chemoresistance. Cancer Cell 2014, 25:350-365.
38. Hanna M., Liu H., Amir J., Sun Y., Morris S.W., Siddiqui M.A., et al. Mechanical regulation of the proangiogenic factor CCN1/CYR61 gene requires the combined activities of MRTF-A and CREB-binding protein histone acetyltransferase. J Biol Chem 2009, 284:23125-23136.
39. Lockman K., Taylor J.M., Mack C.P. The histone demethylase, Jmjd1a, interacts with the myocardin factors to regulate SMC differentiation marker gene expression. Circ Res 2007, 101:e115-e123.
40. Zhang M., Fang H., Zhou J., Herring B.P. A novel role of Brg1 in the regulation of SRF/MRTFA-dependent smooth muscle-specific gene expression. J Biol Chem 2007, 282:25708-25716.
41. Jin Q., Yu L.R., Wang L., Zhang Z., Kasper L.H., Lee J.E., et al. Distinct roles of GCN5/PCAF-mediated H3K9ac and CBP/p300-mediated H3K18/27ac in nuclear receptor transactivation. EMBO J 2011, 30:249-262.
42. Pirola L., Balcerczyk A., Tothill R.W., Haviv I., Kaspi A., Lunke S., et al. Genome-wide analysis distinguishes hyperglycemia regulated epigenetic signatures of primary vascular cells. Genome Res 2011, 21:1601-1615.
43. Awad S., Kunhi M., Little G.H., Bai Y., An W., Bers D., et al. Nuclear CaMKII enhances histone H3 phosphorylation and remodels chromatin during cardiac hypertrophy. Nucleic Acids Res 2013, 41(16):7656-7672.
44. Sundaresan N.R., Vasudevan P., Zhong L., Kim G., Samant S., Parekh V., et al. The sirtuin SIRT6 blocks IGF-Akt signaling and development of cardiac hypertrophy by targeting c-Jun. Nat Med 2012, 18:1643-1650.
45. Morita T., Mayanagi T., Sobue K. Dual roles of myocardin-related transcription factors in epithelial mesenchymal transition via slug induction and actin remodeling. J Cell Biol 2007, 179:1027-1042.
46. Feinberg A.P. Phenotypic plasticity and the epigenetics of human disease. Nature 2007, 447:433-440.
47. Shen H., Laird P.W. Interplay between the cancer genome and epigenome. Cell 2013, 153:38-55.
48. Feng D., Lazar M.A. Clocks, metabolism, and the epigenome. Mol Cell 2012, 47:158-167.
49. Cen B., Selvaraj A., Burgess R.C., Hitzler J.K., Ma Z., Morris S.W., et al. Megakaryoblastic leukemia 1, a potent transcriptional coactivator for serum response factor (SRF), is required for serum induction of SRF target genes. Mol Cell Biol 2003, 23:6597-6608.
50. Koga K., Takaesu G., Yoshida R., Nakaya M., Kobayashi T., Kinjyo I., et al. Cyclic adenosine monophosphate suppresses the transcription of proinflammatory cytokines via the phosphorylated c-Fos protein. Immunity 2009, 30:372-383.
51. Glenn D.J., Rahmutula D., Nishimoto M., Liang F., Gardner D.G. Atrial natriuretic peptide suppresses endothelin gene expression and proliferation in cardiac fibroblasts through a GATA4-dependent mechanism. Cardiovasc Res 2009, 84:209-217.
52. Uchil P.D., Hinz A., Siegel S., Coenen-Stass A., Pertel T., Luban J., et al. TRIM protein-mediated regulation of inflammatory and innate immune signaling and its association with antiretroviral activity. J Virol 2013, 87:257-272.
53. Hilfiker-Kleiner D., Hilfiker A., Castellazzi M., Wollert K.C., Trautwein C., Schunkert H., et al. JunD attenuates phenylephrine-mediated cardiomyocyte hypertrophy by negatively regulating AP-1 transcriptional activity. Cardiovasc Res 2006, 71:108-117.
54. Arnould T., Sellin L., Benzing T., Tsiokas L., Cohen H.T., Kim E., et al. Cellular activation triggered by the autosomal dominant polycystic kidney disease gene product PKD2. Mol Cell Biol 1999, 19:3423-3434.
55. Pariente N., Mao S.H., Morizono K., Chen I.S. Efficient targeted transduction of primary human endothelial cells with dual-targeted lentiviral vectors. J Gene Med 2008, 10:242-248.
56. Fang M., Kong X., Li P., Fang F., Wu X., Bai H., et al. RFXB and its splice variant RFXBSV mediate the antagonism between IFNgamma and TGFbeta on COL1A2 transcription in vascular smooth muscle cells. Nucleic Acids Res 2009, 37:4393-4406.
57. Li P., Zhao Y., Wu X., Xia M., Fang M., Iwasaki Y., et al. Interferon gamma (IFN-gamma) disrupts energy expenditure and metabolic homeostasis by suppressing SIRT1 transcription. Nucleic Acids Res 2012, 40:1609-1620.
58. Xu Y., Luchsinger L., Lucey E.C., Smith B.D. The effect of class II transactivator mutations on bleomycin-induced lung inflammation and fibrosis. Am J Respir Cell Mol Biol 2011, 44:898-905.
59. Wu X., Kong X., Chen D., Li H., Zhao Y., Xia M., et al. SIRT1 links CIITA deacetylation to MHC II activation. Nucleic Acids Res 2011, 39:9549-9558.